Andover, MA, United States of America

Utpal Majumder

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Andover, MA (US) (2019 - 2020)
  • Tewksbury, MA (US) (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Utpal Majumder: Innovator in Cancer Treatment

Introduction

Utpal Majumder is a notable inventor based in Andover, MA (US), recognized for his contributions to cancer treatment through innovative patent developments. He holds three patents that focus on advanced methods and compositions for detecting and treating cancer.

Latest Patents

One of his latest patents is titled "Chlorotoxin agents and uses thereof." This invention provides compositions and methods related to the detection and treatment of cancer, particularly tumors that express Neuropilin 1 (NRP1). The methods include administering a chlorotoxin agent to subjects suffering from or susceptible to such cancers. The patent also discusses the use of chlorotoxin polypeptides combined with a payload moiety as a covalent conjugate.

Another significant patent is "Eribulin-based antibody-drug conjugates and methods of use." This invention discloses linker toxins and antibody-drug conjugates that target human oncology antigen markers, such as folate receptor alpha. These conjugates comprise an eribulin drug moiety, which can be internalized into cells expressing the target antigens. The patent outlines methods and compositions for treating cancer using these antibody-drug conjugates.

Career Highlights

Utpal Majumder has worked with prominent companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Eisai Inc. His work has significantly impacted the field of oncology, particularly in developing targeted therapies for cancer treatment.

Collaborations

Throughout his career, Majumder has collaborated with notable colleagues, including Earl Albone and Xin Cheng. These partnerships have contributed to the advancement of his research and innovations in cancer therapies.

Conclusion

Utpal Majumder's innovative work in cancer treatment through his patents demonstrates his commitment to improving patient outcomes. His contributions to the field of oncology are invaluable and continue to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…